NIH-funded research R01 grant

Understanding how maternal weight affects placenta development in preeclampsia

Official title: Mechanisms of maternal obesity and feto-placental development in preeclampsia

Funded at Colorado State University · NIH-11145759 · Data updated 2026-11-12

This project looks at how a mother's weight and inflammation might lead to preeclampsia by affecting how the placenta grows.

More Obesity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColorado State University
NIH-funded
Lab location1 site (Fort Collins, United States)
Project startAugust 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$501,307
NIH project number5R01HD114145-02
Project IDNIH-11145759 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals experiencing or at risk for preeclampsia, particularly those with obesity, might benefit from future treatments developed from this research.

Less likely to help

Patients whose preeclampsia is not linked to maternal obesity or inflammation may not directly benefit from this specific line of research.

What this research studies

Preeclampsia is a serious pregnancy complication marked by high blood pressure and protein in the urine, often linked to problems with the placenta. We believe that a mother's body fat can increase inflammation, which then interferes with the placenta's normal development. Our work aims to discover how inflammatory signals from maternal fat tissue might reduce the helpful immune cells and factors needed for a healthy maternal-fetal connection. We will use a special mouse model that develops preeclampsia to explore these connections. By understanding these early processes, we hope to find new ways to prevent or treat preeclampsia.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent or treat preeclampsia by targeting inflammation related to maternal weight.

How similar studies have gone: While the link between maternal obesity, inflammation, and preeclampsia is recognized, this specific approach to understanding the detailed mechanisms at the maternal-fetal interface using leptin and single-cell sequencing in this mouse model is novel.

Where this research is happening

  • Colorado State University
    Fort Collins, United States
    Active

Researchers

  • Principal investigator: Sones, Jennifer Liford — Colorado State University
  • Study coordinator: Sones, Jennifer Liford

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.